Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus.
Desmedt V, Jauregui-Amezaga A, Fierens L, Aspeslagh S, Dekervel J, Wauters E, Peeters M, Sabino J, Crapé L, Somers M, Hoorens A, Dutré J, Lobatón T; for BIRD (Belgian IBD Research and Development); Belgian Society of Medical Oncology (BSMO); Belgian group of Digestive Oncology (BGDO); BeRS (Belgian Respiratory Society); participants of the collaborator group in the modified Delphi consensus for the Position Statement on the management of the immune checkpoint inhibitor induced colitis.
Desmedt V, et al.
Eur J Cancer. 2023 Jul;187:36-57. doi: 10.1016/j.ejca.2023.03.025. Epub 2023 Mar 25.
Eur J Cancer. 2023.
PMID: 37116287
Review.